Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
University of Sydney, Sydney, NSW, Australia.
Eur J Neurol. 2016 Jun;23(6):1058-63. doi: 10.1111/ene.12983. Epub 2016 Mar 11.
Fisher syndrome (FS) may overlap with Guillain-Barré syndrome (GBS), in particular the pharyngeal-cervical-brachial variant form (PCB-GBS), or Bickerstaff brainstem encephalitis (BBE). Our aim was to elucidate the frequency of this overlap and the patterns of clinical progression in patients with FS.
Sixty consecutive patients with FS were studied. FS/PCB-GBS was diagnosed when the patients developed pharyngeal, cervical and/or brachial weakness. Patients with flaccid tetraparesis were diagnosed as having FS/conventional GBS. FS/BBE was defined as the development of consciousness disturbances.
All 60 patients initially developed the FS clinical triad alone (pure FS). Of these, 30 (50%) patients had pure FS throughout their course, whereas the remaining 50% of patients showed an overlap: PCB-GBS in 14 (23%) patients, conventional GBS in nine (15%) patients and BBE in seven (12%) patients. The median (range) durations from FS onset to progression to FS/PCB-GBS, FS/GBS or FS/BBE were 5 (1-7), 3 (1-4) and 3 (1-5) days, respectively. Patients with overlap syndromes more frequently received immune-modulating treatment, and the outcomes were generally favourable. The frequencies of positivity for anti-GQ1b, GT1a, GD1a, GD1b, GalNAc-GD1a and GM1 antibodies were not significantly different amongst the four groups.
Of the patients with pure FS, 50% later developed an overlap with PCB-GBS, conventional GBS or BBE. The overlap occurred within 7 days of FS onset; thus, physicians should pay attention to the possible development of this overlap during the first week after FS onset.
Fisher 综合征(FS)可能与吉兰-巴雷综合征(GBS)重叠,特别是咽颈臂型(PCB-GBS)或 Bickerstaff 脑干脑炎(BBE)。我们的目的是阐明 FS 患者重叠的频率和临床进展模式。
研究了 60 例连续的 FS 患者。当患者出现咽部、颈部和/或臂部无力时,诊断为 FS/PCB-GBS。诊断为弛缓性四肢瘫痪的患者为 FS/常规 GBS。FS/BBE 的定义为意识障碍的发展。
所有 60 例患者最初均单独出现 FS 临床三联征(单纯 FS)。其中,30 例(50%)患者整个病程中均为单纯 FS,而其余 50%的患者存在重叠:14 例(23%)为 PCB-GBS,9 例(15%)为常规 GBS,7 例(12%)为 BBE。从 FS 发病到进展为 FS/PCB-GBS、FS/GBS 或 FS/BBE 的中位(范围)时间分别为 5(1-7)、3(1-4)和 3(1-5)天。重叠综合征患者更频繁地接受免疫调节治疗,且结局通常良好。在这 4 组中,抗 GQ1b、GT1a、GD1a、GD1b、GalNAc-GD1a 和 GM1 抗体的阳性率无显著差异。
在单纯 FS 患者中,有 50%的患者后来发展为与 PCB-GBS、常规 GBS 或 BBE 的重叠。重叠发生在 FS 发病后 7 天内;因此,医生应在 FS 发病后第一周内注意可能发生这种重叠。